11 Biggest Issues Facing By Pharmaceutical Healthcare Industry?

By Author: Sravani
Total Articles: 1
Comment this article

India's healthcare system, in particular, has a very low overhead and the country is able to provide technology at a lower cost. Because of these factors, India is becoming a favorite destination for medical device companies.

1.Another answer to that question might be the rising costs of medications in the United States and elsewhere in the world. As people become more concerned about the rising costs of medications, they are turning to other countries for solutions. China, for example, has developed a robust drug manufacturing industry and it is exporting large quantities of pharmaceutical products to the United States and other countries.

2.India is not a typical country for this market. India is one of the fastest growing countries for the manufacture of generic drugs. In the last decade, India has ranked first for its exports of generic drugs. That is one of the reasons why India is quickly becoming one of the fastest growing markets for these products.

3.India is not a typical country for this market. Bio pharmaceutical plants in India have been growing rapidly over the last decade and a half. India ...
... is one of the fastest growing markets for these drugs in the world.

4.This one comes down to one simple answer - China. China is emerging as one of the fastest growing markets for drugs like Statinol. The Chinese market is growing faster than the overall economy of the country. That is why China is one of the major reasons for the success of the Biopharmaceutical plants in India.

5.That is a tough one to answer because there are certainly a number of problems. One of the biggest challenges for the pharmaceutical manufacturing organization in India is that they must be able to make their mark in the developing world.

6.One possible answer could be the cost of drugs coming from developing countries. Most drugs come from the developed world and most of those come with a hefty price tag. As developing countries develop better health care infrastructure, they can produce high quality drugs at a lower cost. India is starting to change this trend. It appears that Indian drug manufacturers are starting to use private capital to fund R&D.

7.Perhaps the biggest challenge is that drugs are very expensive. So even if a drug gets developed and comes out at a decent price, there won't be enough of them to make a dent in the huge investment portfolio required by the big pharmaceutical companies. There will probably be an upper limit on the price that they will be willing to pay for a drug.

8.That would be the lack of any new drugs coming on the market. We have already seen many examples of this in the developing world. Often, the drugs that get developed and approved are not ready to enter the market before the end of the year.

9.In a word, cost. The costs of developing drugs in developing countries are too high. In fact, they are so high that the pharmaceutical companies won't be able to finance the R&D costs. Unless the United States or other first world countries start providing funds for research and development, this will continue to be a major problem.

10. Aging Baby Boomers are coming to the age where they think they are going to need several years or decades to recover from their diseases. Unfortunately, most of them don't have the money to invest in pharmaceuticals. Even those who do have insurance won't be able to afford the drugs in the long run.

Willing to start a new pharma industry in Hyderabad worried about where to find consultants? If yes, kindly register with SolutionBuggy. It connects with 800 + trusted & verified consultants. Our best Pharma Consultants in hyderabad helps you start your own Pharma Industry.